Antiplatelet therapy for acute coronary syndrome treated with percutaneous coronary intervention: New Developments Conclusions

被引：0
|
作者：
Lopez-Sendon, Jose L. [2 ]
Storey, Robert F. [1 ]
机构：
[1] Univ Sheffield, Sheffield, S Yorkshire, England
[2] Hosp Univ La Paz, Madrid, Spain
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2009年 / 11卷 / 0G期
关键词：
CLOPIDOGREL; PRASUGREL; TRIAL;
D O I：
10.1093/eurheartj/sup039
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：G25 / G26
页数：2
相关论文
共 50 条
  • [1] Antiplatelet therapy for acute coronary syndrome treated with percutaneous coronary intervention: New Developments Introduction
    Lopez-Sendon, Jose L.
    Storey, Robert F.
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2009, 11 (0G) : G2 - G3
  • [2] Optimizing antiplatelet therapy in acute coronary syndrome and percutaneous coronary intervention
    Faxon, David P.
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2012, 79 (02) : 181 - 197
  • [3] The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention
    Tereshchenko, Andrei S.
    Merkulov, Evgeny, V
    Samko, Anatoly N.
    Abugov, Sergey A.
    [J]. RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2019, 15 (02) : 277 - 281
  • [4] Antiplatelet Therapy and Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome and Thrombocytopenia
    Yusuf, Syed Wamique
    Iliescu, Cezar
    Bathina, Jaya D.
    Daher, Iyad N.
    Durand, Jean-Bernard
    [J]. TEXAS HEART INSTITUTE JOURNAL, 2010, 37 (03) : 336 - 340
  • [5] Antiplatelet Therapy for Elderly Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Fioretti, Vincenzo
    Sperandeo, Luca
    Gerardi, Donato
    Di Fazio, Aldo
    Stabile, Eugenio
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (14)
  • [6] Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention
    Bagai, Akshay
    Bhatt, Deepak L.
    Eikelboom, John W.
    Mancini, G. B. John
    Cohen, Eric A.
    Vijayaraghavan, Ram
    Cheema, Asim N.
    Udell, Jacob A.
    Niznick, Joel
    Tanguay, Jean-Francois
    Verma, Subodh
    Mehta, Shamir R.
    [J]. CIRCULATION, 2016, 133 (21) : 2094 - 2098
  • [7] Optimal duration of dual antiplatelet therapy post percutaneous coronary intervention in acute coronary syndrome
    Deharo, Pierre
    Cuisset, Thomas
    [J]. TRENDS IN CARDIOVASCULAR MEDICINE, 2020, 30 (04) : 198 - 202
  • [8] Duration of Dual Antiplatelet Therapy in Patients with an Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Bavishi, Chirag
    Trivedi, Vrinda
    Singh, Mandeep
    Katz, Edward
    Messerli, Franz H.
    Bangalore, Sripal
    [J]. AMERICAN JOURNAL OF MEDICINE, 2017, 130 (11): : 1325.e1 - 1325.e12
  • [9] Genotype-guided antiplatelet therapy for acute coronary syndrome percutaneous coronary intervention patients: A new standard of care?
    Ashley, Kellan E.
    Hillegass, William B.
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2021, 97 (05) : 795 - 796
  • [10] Outpatient Trends in Dual Antiplatelet Therapy Following Acute Coronary Syndrome and Primary Percutaneous Coronary Intervention
    Buchanan, Kyle D.
    Alraies, M. Chadi
    Rogers, Toby
    Steinvil, Arie
    Gai, Jiaxiang
    Torguson, Rebecca
    Koifman, Edward
    Ben-Dor, Itsik
    Pichard, Augusto D.
    Satler, Lowell
    Waksman, Ron
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (03) : S14 - S14
12345